Ludger is an industry leader specialising in glycomics and glycoanalytical technology to support biopharmaceutical realisation and translational medicine.

Our technology originated at the University of Oxford, UK and is used in the quality control of FDA- and EMA-approved biopharmaceuticals worldwide. We provide Glycan analytical services, kits, and reagents for detailed characterisation of glyco-conjugates. We also provide support for validation studies and we provide consultation services for biopharma and regulators and Ludger’s technology can be used to support IND submissions.